Proton-pump inhibitor use is associated with lower urinary magnesium excretion - Wikidata - awgldk - TriplyDB

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

http://www.wikidata.org/entity/Q35038136

about

Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.The role of magnesium sulfate in the intensive care unit.Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.

P2860

Q26765064-7526624A-AC00-4F28-83F9-AB6EAF2F2C40 Q35614268-2D1EADC2-3415-44AF-BFBD-FC4112C68077 Q35744487-A9C386AC-EA07-43F4-A04E-CF4DEADEB3E7 Q35855528-3098B3AE-3754-4AE6-BF1E-00E36B3647BF Q37013934-8BAF56EF-6054-4F75-81B1-43C9F2FACE8D Q38638067-35EFB532-AA63-4245-A474-882E65EA5AC7 Q39427028-AAF00A6F-8CAF-499E-BCE7-FFF155642F81 Q39523340-B6CD5FA7-F457-4481-B192-AD1F5AA60FA2

P2860

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

http://www.wikidata.org/entity/Q35038136

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@ast

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@en

type

label

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@ast

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@en

prefLabel

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@ast

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@en

P1433

Q35038136-A137C021-805F-4DE9-AEA3-8B8FB700E1B7

P1476

Q35038136-C8FA3FED-5877-48E8-AD46-AF2CC47ECA0F

P2093

Q35038136-51906209-449A-4F60-872E-0AE7C5717C83

Q35038136-6532C1F1-AAD9-41E6-8087-E25BE57721A1

Q35038136-8E86AFCC-7F57-41B8-856D-87EBCB0FEDD2

Q35038136-9A15DAEB-9132-4095-A969-622E40EF4FEC

Q35038136-EFDC1714-378F-4C21-B3B6-6A727F73E733

P2860

Q35038136-145535C7-66F4-4F10-B327-BC6357B07C69

Q35038136-2C5B1EE6-C270-44F3-B5A3-0B894F4B3B10

Q35038136-2DE6422B-C6AF-44A1-97E4-4809C02DBC47

Q35038136-4E2F1499-09A6-41EC-911E-C2457E7BD725

Q35038136-67F09489-B6F9-44CE-B1A7-FD35FBE37AA1

Q35038136-91DA2950-6029-4110-B059-BE4FF5D4DD1D

Q35038136-9B8ACB92-65BE-441C-89DA-4133A82D98D9

Q35038136-A712C719-A007-4B8C-8328-48F7FCB3049D

Q35038136-AD213D26-E757-4FBC-B35D-B8CA8A06E449

Q35038136-AF6BD9E5-B844-4A36-ACB0-F580BFFF42EF

P304

Q35038136-41C5C51E-A636-484C-A2FE-6893DDE55D1F

P31

Q35038136-6DF35CA5-A734-4EDC-A0CB-F890BF5585CB

P356

Q35038136-8DCA8727-8D1B-471A-A011-48932ED4F73E

P433

Q35038136-7007119B-DD50-406C-87DB-63F770CD9E27

P478

Q35038136-6491740B-1421-4FBC-B97B-D16ACF04006F

P577

Q35038136-059E2267-5C07-4637-B40D-9D8DE5293BAB

P698

Q35038136-DD48B271-517D-4204-B2FF-4CEA17470801

P932

Q35038136-0530EB91-C374-4BE8-A6B3-8B640D7DECC0

P356

P1433

P1476

Proton-pump inhibitor use is associated with lower urinary magnesium excretion

@en

P2093

Jeffrey H William

http://www.w3.org/2001/XMLSchema#string

John Danziger

http://www.w3.org/2001/XMLSchema#string

Kenneth J Mukamal

http://www.w3.org/2001/XMLSchema#string

Najwah Hayman

http://www.w3.org/2001/XMLSchema#string

Rachel Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study

Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.

Omeprazole and refractory hypomagnesaemia.

Systematic review: Proton pump inhibitor-associated acute interstitial nephritis.

Hypomagnesaemia due to use of proton pump inhibitors--a review.

Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.

Proton pump inhibitors and severe hypomagnesaemia.

Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.

P304

798-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NEP.12330

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25142949

http://www.w3.org/2001/XMLSchema#string

P932

4313878

http://www.w3.org/2001/XMLSchema#string